Related Experiment Video

Updated: Jul 19, 2026

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy
07:45

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy

Published on: October 21, 2014

Chronic Granulomatous Disease; fundamental stages in our understanding of CGD

Tracy Assari1

  • 1Molecular Immunology Unit, The Institute of Child Health, University College London and Great Ormond Street Hospital for Children NHS Trust, 30 Guilford Street, London WC1N 3EH, UK. t.assari@ich.ucl.ac.uk

Medical Immunology (London, England)
|September 23, 2006
PubMed

Insights

Chronic granulomatous disease (CGD) impairs children's ability to fight infections. Research has uncovered genetic causes and led to treatments like antibiotics, bone marrow transplants, and gene therapy.

Area of Science:

  • Immunology
  • Genetics
  • Pediatrics

Background:

  • Chronic granulomatous disease (CGD) is a primary immunodeficiency affecting phagocyte function.
  • CGD leads to severe, recurrent infections, historically with high childhood mortality.
  • Understanding CGD has evolved significantly over 50 years.

Purpose of the Study:

  • To review key scientific discoveries in chronic granulomatous disease.
  • To highlight advancements in understanding CGD's pathophysiology and genetics.
  • To discuss the impact of these findings on clinical management and future therapies.

Main Methods:

  • Literature review of seminal studies on chronic granulomatous disease.
  • Analysis of historical and recent research on CGD pathogenesis.
  • Synthesis of information on genetic basis, clinical manifestations, and therapeutic progress.

Main Results:

  • Identified defects in phagocyte oxidative burst capacity in CGD patients.
  • Elucidated the genetic heterogeneity and inheritance patterns of CGD.
  • Documented the efficacy of long-term antibiotic prophylaxis in reducing infection rates.
  • Observed progress in hematopoietic stem cell transplantation and gene therapy approaches.

Conclusions:

  • Scientific breakthroughs have transformed the understanding and management of CGD.
  • Current treatments improve survival, but curative options like transplantation and gene therapy offer long-term solutions.
  • Continued research is crucial for refining CGD therapies and achieving a permanent cure.

More Related Videos

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

Related Concept Videos

Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...